2-FEA Stats & Data

• Identity and purity: Mislabeling and substitutions are common in the NPS market. Where possible, use an official drug checking service (GC‑MS/FT‑IR). If no lab testing is available, test a very small dose first and wait; for oral use, wait at least 2 hours before considering more. Use your own snorting equipment to reduce infection risk.

• Dosing discipline: Start low and go slow. Pre‑measure doses with a milligram scale. For faster routes (insufflated/rectal), pre‑plan a maximum total session amount to reduce chasing effects. TripSit provides a volumetric dosing tool and combination guidance.

• Heat and hydration: Stimulants increase body temperature and fluid loss. Take regular cool‑down breaks if active/hot, sip fluids slowly, and avoid overhydration. A practical rule-of-thumb from clubbing harm‑reduction: about one pint (~500 mL) per hour when exerting, with breaks; do not force excessive water (risk of hyponatremia).

• Cardiovascular risk: Like other synthetic stimulants, 2-FEA may elevate heart rate and blood pressure. Avoid combining with other stimulants, and people with cardiovascular disease should be especially cautious or avoid use.

• Redosing/compulsion: Stimulants can promote compulsive redosing. To reduce risk, plan session limits, store the remainder out of reach/sight, and consider having a trusted person hold the supply.

• Nasal health: If insufflating, use your own straw/tube, avoid frequent large lines, and gently rinse with saline after sessions to reduce irritation.

• Sleep and comedown: Expect insomnia and a low mood the following day. Prioritize rest, nutrition, and rehydration. Avoid using alcohol, benzodiazepines, or opioids to force sleep due to interaction risks.

• Evidence limits: There are no controlled human pharmacokinetic studies for 2-FEA. All typical dose/duration ranges here are from user reports; individual responses vary widely. Prefer lab confirmation and conservative titration. (General NPS preparedness guidance.)